id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0528-0005,FDA,FDA-2009-D-0528,International Conference on Harmonisation; Guidance Availability: E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers,Notice,Notice of Availability,2012-02-21T05:00:00Z,2012,2,2012-02-21T05:00:00Z,,2012-02-21T16:02:23Z,2012-03955,0,0,0900006480fbbd34
FDA-2009-D-0528-0006,FDA,FDA-2009-D-0528,Guidance for Industry; E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers,Other,Guidance,2012-02-21T05:00:00Z,2012,2,2012-02-21T05:00:00Z,,2024-11-12T04:40:09Z,,1,0,0900006480fbac3d
FDA-2009-D-0528-0001,FDA,FDA-2009-D-0528,International Conference on Harmonisation; Draft Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; Availability,Notice,NAD-Notice of Availability of Data,2009-11-10T05:00:00Z,2009,11,2009-11-10T05:00:00Z,2010-01-12T04:59:59Z,2009-11-10T17:26:33Z,E9-27000,0,0,0900006480a54e55
FDA-2009-D-0528-0002,FDA,FDA-2009-D-0528,Draft Guidance: E7 Studies in Support of Special Populations: Geriatrics - Questions & Answers - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-11-10T05:00:00Z,2009,11,2009-11-10T05:00:00Z,,2024-11-07T22:12:42Z,,1,0,0900006480a5521d